Skip to main content
  • menu
  • menu
    • Home
  • TOPICS keyboard_arrow_down

    All Topics

    About Us

    Sign up for the Physician e-News

    Sign up for the Physician e-News Confirm

    Unsubscribe

    Unsubscribe Confirm

Dana-Farber
  • person
  • dana-farber.org
  • Search

Pasi Jänne, MD, PhD

Medical Oncology

Pasi Jänne, MD, PhD

Dr. Jänne received his MD and PhD from the University of Pennsylvania in 1996. He completed postgraduate training in internal medicine at Brigham and Women's Hospital and in medical oncology at DFCI in 2001. He is the director of the Lowe Center for Thoracic Oncology and the Scientific Director of the Belfer Center for Applied Cancer Science. His main research interests include studying the therapeutic relevance of oncogenic alterations in lung cancer. He was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations and has led the development of therapeutic strategies for patients with EGFR mutant lung cancer.

View Full Profile


Related Videos

Lung Cancer Research at ESMO Video

Lung Cancer Research at ESMO

Dana-Farber's Pasi A. Jänne, MD, PhD, provides insight on DESTINY-Lung01 trial in lung cancer highlighted at ESMO 2021.

ASCO22: Pasi Janne, MD, PhD on lung cancer research Video

ASCO22: Pasi Janne, MD, PhD on lung cancer research

Lung cancer research at #ASCO22. Non-small cell lung cancers with KRAS mutation respond to experimental drug adagrasib which also shows activity in brain metastasis. Dana-Farber's Pasi Janne, MD, PhD, is senior author and explains more.


Powered by BroadcastMedBROADCASTMED